EP42675 pharmacodynamics were characterized by a long-lasting , dose-dependent increase in activated clotting time , ecarin clotting time , thrombin time , anti-FXa activity , activated partial thromboplastin time , prothrombin time , and a decrease in endogenous thrombin potential , measured by a thrombin generation test .